Cargando…

Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?

Functional genes of HIV-1 like the tat express proteins essential for viral survival and propagation. There are variations reported in levels of Tat transactivation among the different subtypes of HIV-1. This study looked at the amino acid differences in the different regions of Tat protein (exon 1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandathil, Abraham Joseph, Kannangai, Rajesh, Abraham, Oriapadickal Cherian, Pulimood, Susanne Alexander, Sridharan, Gopalan
Formato: Texto
Lenguaje:English
Publicado: Biomedical Informatics Publishing Group 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951709/
https://www.ncbi.nlm.nih.gov/pubmed/20975916
_version_ 1782187728727703552
author Kandathil, Abraham Joseph
Kannangai, Rajesh
Abraham, Oriapadickal Cherian
Pulimood, Susanne Alexander
Sridharan, Gopalan
author_facet Kandathil, Abraham Joseph
Kannangai, Rajesh
Abraham, Oriapadickal Cherian
Pulimood, Susanne Alexander
Sridharan, Gopalan
author_sort Kandathil, Abraham Joseph
collection PubMed
description Functional genes of HIV-1 like the tat express proteins essential for viral survival and propagation. There are variations reported in levels of Tat transactivation among the different subtypes of HIV-1. This study looked at the amino acid differences in the different regions of Tat protein (exon 1) of subtype B and C strains of HIV-1 and tried to observe a molecular basis for protein function. HIV-1 sequences of subtype B (n=30) and C (n=60) strains were downloaded from HIV-1 Los Alamos data base. Among the 60 subtype C strain sequences, 30 each were from India and Africa. A HIV-1 Tat protein (exon 1) sequence, the consensus B and C sequence was obtained from the ’sequence search interface‘ in the Los Alamos HIV-1 sequence data. The sequences were visualized using Weblogo and the RNA binding regions of the three consensus sequences were also determined using BindN software program. Compared to subtype B, there was a high level of divergence in the auxiliary domain of tat exon 1 (amino acid positions 58- 69). The net charge of the subtype C (Indian) Tat protein (exon 1) auxiliary domain was -1.9 at pH 7 and it had an isoelectric point of 4.1. The net charge of the subtype C (African) auxiliary domain was -2.9 at pH 7 and it had an isoelectric point of 3.7 while the net charge of same region in subtype B was -0.9 at pH 7 with an isoelectric point of 4.9. The ratio of the hydrophilic residues to the total number of residues was 60% in the in both the Indian and African subtype C in the auxiliary domain while this was 50% in subtype B. The consensus subtype B sequence was found to have 36 RNA binding sites while subtype C (India) had 33 and subtype C (Africa) had 32 RNA binding sites. The HIV-1 Tat-TAR interaction is a potential target for inhibitors and being considered for its potential use in HIV-1 vaccines. Development of such inhibitor/vaccines would have to take into consideration the variation in amino acid sequence analyzed in this study as this could determine epitope presentation on MHC class I antigen for afferent immune response.
format Text
id pubmed-2951709
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Biomedical Informatics Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-29517092010-10-25 Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development? Kandathil, Abraham Joseph Kannangai, Rajesh Abraham, Oriapadickal Cherian Pulimood, Susanne Alexander Sridharan, Gopalan Bioinformation Hypothesis Functional genes of HIV-1 like the tat express proteins essential for viral survival and propagation. There are variations reported in levels of Tat transactivation among the different subtypes of HIV-1. This study looked at the amino acid differences in the different regions of Tat protein (exon 1) of subtype B and C strains of HIV-1 and tried to observe a molecular basis for protein function. HIV-1 sequences of subtype B (n=30) and C (n=60) strains were downloaded from HIV-1 Los Alamos data base. Among the 60 subtype C strain sequences, 30 each were from India and Africa. A HIV-1 Tat protein (exon 1) sequence, the consensus B and C sequence was obtained from the ’sequence search interface‘ in the Los Alamos HIV-1 sequence data. The sequences were visualized using Weblogo and the RNA binding regions of the three consensus sequences were also determined using BindN software program. Compared to subtype B, there was a high level of divergence in the auxiliary domain of tat exon 1 (amino acid positions 58- 69). The net charge of the subtype C (Indian) Tat protein (exon 1) auxiliary domain was -1.9 at pH 7 and it had an isoelectric point of 4.1. The net charge of the subtype C (African) auxiliary domain was -2.9 at pH 7 and it had an isoelectric point of 3.7 while the net charge of same region in subtype B was -0.9 at pH 7 with an isoelectric point of 4.9. The ratio of the hydrophilic residues to the total number of residues was 60% in the in both the Indian and African subtype C in the auxiliary domain while this was 50% in subtype B. The consensus subtype B sequence was found to have 36 RNA binding sites while subtype C (India) had 33 and subtype C (Africa) had 32 RNA binding sites. The HIV-1 Tat-TAR interaction is a potential target for inhibitors and being considered for its potential use in HIV-1 vaccines. Development of such inhibitor/vaccines would have to take into consideration the variation in amino acid sequence analyzed in this study as this could determine epitope presentation on MHC class I antigen for afferent immune response. Biomedical Informatics Publishing Group 2009-12-12 /pmc/articles/PMC2951709/ /pubmed/20975916 Text en © 2009 Biomedical Informatics Publishing Group This is an open-access article, which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original author and source are credited.
spellingShingle Hypothesis
Kandathil, Abraham Joseph
Kannangai, Rajesh
Abraham, Oriapadickal Cherian
Pulimood, Susanne Alexander
Sridharan, Gopalan
Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?
title Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?
title_full Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?
title_fullStr Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?
title_full_unstemmed Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?
title_short Amino acid sequence divergence of Tat protein (exon1)of subtype B and C HIV-1 strains: Does it have implications for vaccine development?
title_sort amino acid sequence divergence of tat protein (exon1)of subtype b and c hiv-1 strains: does it have implications for vaccine development?
topic Hypothesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951709/
https://www.ncbi.nlm.nih.gov/pubmed/20975916
work_keys_str_mv AT kandathilabrahamjoseph aminoacidsequencedivergenceoftatproteinexon1ofsubtypebandchiv1strainsdoesithaveimplicationsforvaccinedevelopment
AT kannangairajesh aminoacidsequencedivergenceoftatproteinexon1ofsubtypebandchiv1strainsdoesithaveimplicationsforvaccinedevelopment
AT abrahamoriapadickalcherian aminoacidsequencedivergenceoftatproteinexon1ofsubtypebandchiv1strainsdoesithaveimplicationsforvaccinedevelopment
AT pulimoodsusannealexander aminoacidsequencedivergenceoftatproteinexon1ofsubtypebandchiv1strainsdoesithaveimplicationsforvaccinedevelopment
AT sridharangopalan aminoacidsequencedivergenceoftatproteinexon1ofsubtypebandchiv1strainsdoesithaveimplicationsforvaccinedevelopment